Full Text View
Tabular View
No Study Results Posted
Related Studies
Neurobiology of Opioid Dependence: 1 - 1
This study has been completed.
Study NCT00000192   Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 20, 1999   Last Updated: June 23, 2005   History of Changes

September 20, 1999
June 23, 2005
January 1995
 
  • Behavioral, subjective, measures of naloxone-precipitated opiate withdrawal
  • Phsyiological, neuroendocrine measures of naloxone-precipitated opiate withdrawal
Same as current
Complete list of historical versions of study NCT00000192 on ClinicalTrials.gov Archive Site
 
 
 
Neurobiology of Opioid Dependence: 1 - 1
Neurobiology of Opioid Dependence: 1

The purpose of this study is to evaluate the effects of lamotrigine on naloxone-precipitated opiate withdrawal.

 
Phase II
Interventional
Treatment, Double-Blind, Placebo Control
Opioid-Related Disorders
Drug: Lamotrigine
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
0
 
 

Please contact site for information.

Both
 
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00000192
 
NIDA-00191-1, K20-00191-1
National Institute on Drug Abuse (NIDA)
Yale University
Principal Investigator: Marc I Rosen, M.D. VA Connecticut Healthcare System
National Institute on Drug Abuse (NIDA)
October 1996

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP